UBS Group Forecasts Strong Price Appreciation for DuPont de Nemours (NYSE:DD) Stock

DuPont de Nemours (NYSE:DDGet Free Report) had its price objective hoisted by equities researchers at UBS Group from $49.00 to $56.00 in a report issued on Wednesday, MarketBeat.com reports. The firm currently has a “buy” rating on the basic materials company’s stock. UBS Group’s price target points to a potential upside of 13.49% from the company’s previous close.

Several other brokerages have also recently issued reports on DD. Citigroup upped their price target on shares of DuPont de Nemours from $47.00 to $50.00 and gave the company a “buy” rating in a research report on Tuesday, February 3rd. Mizuho boosted their price objective on shares of DuPont de Nemours from $46.00 to $52.00 and gave the stock an “outperform” rating in a research note on Tuesday. Royal Bank Of Canada increased their price objective on DuPont de Nemours from $48.00 to $51.00 and gave the company an “outperform” rating in a report on Wednesday, January 21st. Wolfe Research raised their target price on DuPont de Nemours from $44.00 to $49.00 and gave the stock an “outperform” rating in a research report on Friday, January 16th. Finally, Argus cut their target price on DuPont de Nemours from $86.00 to $52.00 and set a “buy” rating on the stock in a report on Thursday, February 5th. Twelve research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, DuPont de Nemours has a consensus rating of “Moderate Buy” and an average target price of $50.46.

Check Out Our Latest Research Report on DuPont de Nemours

DuPont de Nemours Trading Down 4.2%

Shares of DD stock opened at $49.34 on Wednesday. DuPont de Nemours has a twelve month low of $22.50 and a twelve month high of $52.66. The stock’s fifty day simple moving average is $43.10 and its 200 day simple moving average is $37.07. The company has a quick ratio of 1.63, a current ratio of 2.42 and a debt-to-equity ratio of 0.22. The firm has a market capitalization of $20.67 billion, a P/E ratio of -26.53, a P/E/G ratio of 3.66 and a beta of 1.10.

DuPont de Nemours (NYSE:DDGet Free Report) last announced its quarterly earnings results on Tuesday, February 10th. The basic materials company reported $0.46 EPS for the quarter, beating analysts’ consensus estimates of $0.43 by $0.03. The firm had revenue of $1.69 billion for the quarter, compared to analyst estimates of $1.69 billion. DuPont de Nemours had a positive return on equity of 7.37% and a negative net margin of 7.03%.The business’s revenue for the quarter was up .2% on a year-over-year basis. During the same period last year, the firm posted $1.13 earnings per share. DuPont de Nemours has set its FY 2026 guidance at 2.250-2.300 EPS and its Q1 2026 guidance at 0.480-0.480 EPS. As a group, sell-side analysts predict that DuPont de Nemours will post 4.38 EPS for the current fiscal year.

DuPont de Nemours announced that its Board of Directors has approved a share buyback plan on Thursday, November 6th that permits the company to buyback $2.00 billion in outstanding shares. This buyback authorization permits the basic materials company to buy up to 12.2% of its shares through open market purchases. Shares buyback plans are typically a sign that the company’s management believes its stock is undervalued.

Insider Transactions at DuPont de Nemours

In related news, CEO Lori Koch sold 9,011 shares of the company’s stock in a transaction dated Friday, November 28th. The stock was sold at an average price of $39.46, for a total transaction of $355,574.06. Following the sale, the chief executive officer owned 288,326 shares in the company, valued at $11,377,343.96. This represents a 3.03% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Erik T. Hoover sold 6,005 shares of the firm’s stock in a transaction that occurred on Friday, November 28th. The stock was sold at an average price of $39.79, for a total value of $238,938.95. Following the sale, the senior vice president directly owned 112,101 shares of the company’s stock, valued at $4,460,498.79. This represents a 5.08% decrease in their position. The disclosure for this sale is available in the SEC filing. Company insiders own 0.61% of the company’s stock.

Hedge Funds Weigh In On DuPont de Nemours

Several institutional investors have recently added to or reduced their stakes in DD. Advisors Asset Management Inc. grew its position in shares of DuPont de Nemours by 588.2% during the 4th quarter. Advisors Asset Management Inc. now owns 2,918 shares of the basic materials company’s stock worth $117,000 after buying an additional 2,494 shares during the period. FineMark National Bank & Trust boosted its stake in DuPont de Nemours by 21.3% during the fourth quarter. FineMark National Bank & Trust now owns 13,894 shares of the basic materials company’s stock worth $559,000 after acquiring an additional 2,438 shares in the last quarter. Advocate Investing Services LLC bought a new position in DuPont de Nemours during the fourth quarter worth $68,000. Federation des caisses Desjardins du Quebec grew its holdings in DuPont de Nemours by 36.0% in the fourth quarter. Federation des caisses Desjardins du Quebec now owns 71,105 shares of the basic materials company’s stock worth $2,858,000 after purchasing an additional 18,831 shares during the period. Finally, HRT Financial LP bought a new stake in DuPont de Nemours in the fourth quarter valued at $8,669,000. 73.96% of the stock is owned by institutional investors and hedge funds.

Key DuPont de Nemours News

Here are the key news stories impacting DuPont de Nemours this week:

  • Positive Sentiment: Multiple major brokers raised price targets and kept buy/overweight calls (Citigroup, Jefferies, UBS, Wells Fargo, KeyCorp, BMO, Wolfe), boosting upside thesis and supporting the stock’s recent rally. Wolfe Research Raises PT
  • Positive Sentiment: DuPont reported better‑than‑expected Q4 results and provided FY guidance, which pushed the shares to a one‑year high and underpins the upgrades. Q4 Results & Guidance
  • Positive Sentiment: Product recognition: DuPont’s FilmTec™ Fortilife™ XC160UHP reverse‑osmosis element was named an Edison Awards finalist — a modest positive for long‑term growth in water/wastewater markets. Edison Awards Finalist
  • Neutral Sentiment: Morgan Stanley remains on a hold rating for DD, which tempers the otherwise bullish analyst momentum and gives some investors pause. Morgan Stanley Hold
  • Neutral Sentiment: Several retail/investor pieces question whether the recent run makes DD less attractive near‑term (“Is it too late…”), highlighting valuation concerns that can limit further immediate buying. Valuation Commentary
  • Negative Sentiment: Net effect today: profit‑taking and selling into strength after the multi‑broker upgrade wave and the one‑year high—mixed analyst signals (some holds/valuation cautions) left the stock vulnerable to a pullback on higher volume.

DuPont de Nemours Company Profile

(Get Free Report)

DuPont de Nemours (NYSE: DD) is a global science and engineering company that develops and supplies specialty materials, chemicals and industrial biosciences for a wide range of markets. Headquartered in Wilmington, Delaware, the company traces its origins to 1802 and has evolved through more than two centuries of innovation. In recent history DuPont participated in a major combination with Dow Chemical and subsequent reorganization that refocused the company on differentiated, specialty businesses built around science-based solutions.

DuPont’s operations center on advanced materials and technologies used by manufacturers and OEMs in industries such as transportation, electronics, construction, industrial manufacturing and worker safety.

See Also

Analyst Recommendations for DuPont de Nemours (NYSE:DD)

Receive News & Ratings for DuPont de Nemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DuPont de Nemours and related companies with MarketBeat.com's FREE daily email newsletter.